2-[(4R)-4,5-DIHYDRO-4-ISOPROPYL-2-OXAZOLYL]PYRIDINE, 98%, 5g

3,4-Furandicarboxylic acid, 2,5-dihydro-, 3,4-dimethyl ester, 100mg

(2E)-3-(4-bromophenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

5-Bromo-4-methylnicotinaldehyde, 95.0%, 1g

3-Bromo-9H-carbazole, 98.0%, 5g

1,2-DIHYDRO-3-HYDROXY-2-OXO-4-PYRIDINECARBOXYLIC ACID ETHYL ESTER, 95.0%, 100mg

2,7-dimethylpyrazolo[1,5-a]pyrimidine-5-carboxylic acid, 95.0%, 5g

Guko sleeves ROTILABO®, 89 mm, 66 mm, 1 Piece

5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole, 500mg

GC capillary column ROTI®Cap-5 MS, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4-CHLORO-1H-INDAZOL-5-OL, 95%, 1g

Methyl (S)-3-(6-bromochroman-2-yl)propanoate, 97%, 1g

3-Bromo-5-fluoroisonicotinonitrile, 95.0%, 100mg